Mayo Clinic Proceedings - Microbiome at the Frontier of Personalized Medicine is organized by Mayo Clinic and will be held from Dec 01, 2017 - Nov 30, 2019.
The target audience for Mayo Clinic Proceedings is primarily internal medicine physicians and other clinicians who wish to advance their current knowledge of clinical medicine and who wish to stay abreast of advances in medical research.
1.00 AMA PRA Category 1 Credit™
One of the premier peer-reviewed clinical journals in general and internal medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications for physicians, with a circulation of approximately 125,000. Mayo Clinic Proceedings is published by Elsevier and sponsored by Mayo Clinic and the Mayo Foundation for Medical Education and Research. The mission of Mayo Clinic Proceedings is to promote the best interest of patients by advancing the knowledge and professionalism of the physician community. Since 2009 the Journal has offered CME credit for specific articles from both the Mayo Clinic for Concise Review for Clinicians and specially commissioned Symposia articles (comprehensive coverage on one topic).
Participation in this activity consists of reviewing articles and responding to a short online test. It is estimated that this activity will take approximately one hour per article. There is no charge for participating in this Journal CME activity.
On completion of this article, you should be able to:
• give examples of the role of microbiome in drug efficacy as well as adverse events;
• critique new studies on treatment efficacy in light of new knowledge learned from the role of microbiome; and
• apply knowledge of the microbiome when explaining therapeutic interventions to patients.
Additional details will be posted as soon as they are available.
Biotechnology, Immunology and Microbiology